NEW

   Today (Wednesday March 17, 2010), at 2:30 p.m., the Senate Special Committee on Aging will be holding a hearing in…

A recent interview with former US Attorney Michael K. Loucks noted that although “The Era of Big Pharma Fraud Cases Is Ending,”…

As part of an ongoing series about how money and conflicts of interest affect medicine and patient care, the Milwaukee Journal…

Last week, The House Committee on Energy and Commerce, Subcommittee on Health held a hearing on “Drug Safety: An Update from the…

This week Congress is in the final leg of passing health care reform, and politicians are  gathering as many votes to save…

Recent evaluations of professional societies and accredited continuing medical education (CME) providers have “further…

In the complex and expensive world of research and development for drugs, there are therapies for conditions known as “orphan…

On Tuesday March 16th at 8:00am, there will be a debate at the American College of Cardiology Meeting in Altanta Georgia on…

An editorial in Nature used the recent appointment of William Chin as a perfect example of why “industry talent should be…

Within the Food and Drug Administration (FDA) is the Office of Criminal Investigations (OCI), which investigates individuals and…